INBLAIR ELEVATE SPF15 MOISTURIZER cream

Inblair Elevate SPF15 Moisturizer by

Drug Labeling and Warnings

Inblair Elevate SPF15 Moisturizer by is a Otc medication manufactured, distributed, or labeled by Guangzhou Fantesy Biotechnology Co.,Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredients

Ethylhexyl Methoxycinnamate 5.994%
Ethylhexyl Salicylate 3.5%
Homosalate 2%
Butyl Methoxydibenzoylmethane 1.5%

Purpose

Sunscreen

Uses

Helps prevent sunburn, decreases the risk of skin cancer and early skin
aging if used as directed.

Warnings

For external use only

Do not use

Do not use on damaged or broken skin

When using this product

When using this product, keep out of eyes. Rinse with water to remove.

Stop use

Stop use and ask a doctor if rash occurs.

Keep out of

Keep out of reach of children. In case of ingestion, get medical help or
contact a Poison Control Center right away.

Directions

Apply evenly to clean, dry skin before sun exposure. Apply once-daily. In the
event of prolonged sun exposure, apply standard sunscreen as-needed
throughout day

Other information

Protect this product from excessive heat and direct sun

Inactive ingredients

Water, Glycerin, Caprylic/Capric Triglyceride, Cetearyl Alcohol, Dimethicone,
Niacinamide, Panthenol, Palmitic Acid, Polymethylsilsesquioxane,PEG-20
Stearate, Stearic Acid, Lauric/Myristic/Palmitic/Stearic Glycerides,
Hydroxyacetophenone,1,2-Hexanediol, Tocopheryl Acetate, Dimethiconol,
Glyceryl Stearate, Polyacrylamide, Titanium Dioxide, Polyacrylic Acid,
Xylitylglucoside, Butylene Glycol, C13-14 Isoparaffin, Anhydroxylitol, Sodium
Hyaluronate, Potassium Hydroxide, Benzyl Alcohol, Laureth-7, Disodium EDTA,
Xylitol, Polysorbate20, Phenoxyethanol, Caprylyl Glycol, Carbomer,BHT,
Ethylhexylglycerin, Benzoic Acid, Palmitoyl Pentapeptide-4

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

INBLAIR ELEVATE SPF15 MOISTURIZER 
inblair elevate spf15 moisturizer cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 83447-014
Route of Administration	CUTANEOUS

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ETHYLHEXYL METHOXYCINNAMATE (UNII: 4Y5P7MUD51) (ETHYLHEXYL METHOXYCINNAMATE - UNII:4Y5P7MUD51)	ETHYLHEXYL METHOXYCINNAMATE	5.994 g  in 100 g
BUTYL METHOXYDIBENZOYLMETHANE (UNII: G63QQF2NOX) (BUTYL METHOXYDIBENZOYLMETHANE - UNII:G63QQF2NOX)	BUTYL METHOXYDIBENZOYLMETHANE	1.5 g  in 100 g
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S)	HOMOSALATE	2 g  in 100 g
ETHYLHEXYL SALICYLATE (UNII: 4X49Y0596W) (ETHYLHEXYL SALICYLATE - UNII:4X49Y0596W)	ETHYLHEXYL SALICYLATE	3.5 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
NIACINAMIDE (UNII: 25X51I8RD4)
POLYACRYLAMIDE (1500 MW) (UNII: 5D6TC4BRWV)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
C13-14 ISOPARAFFIN (UNII: E4F12ROE70)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
PEG-20 STEARATE (UNII: NBX892EA57)
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)
CARBOMER (UNII: 0A5MM307FC)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
GLYCERYL STEARATE (UNII: 230OU9XXE4)
POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
BHT (UNII: 1P9D0Z171K)
PANTHENOL (UNII: WV9CM0O67Z)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
XYLITOL (UNII: VCQ006KQ1E)
LAURETH-7 (UNII: Z95S6G8201)
WATER (UNII: 059QF0KO0R)
GLYCERIN (UNII: PDC6A3C0OX)
CAPRYLIC/CAPRIC TRIGLYCERIDE (UNII: C9H2L21V7U)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
PALMITIC ACID (UNII: 2V16EO95H1)
STEARIC ACID (UNII: 4ELV7Z65AP)
LAURIC/MYRISTIC/PALMITIC/STEARIC GLYCERIDES (UNII: 82TZ9D9546)
ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
SODIUM HYALURONATE (UNII: YSE9PPT4TH)
BENZYL ALCOHOL (UNII: LKG8494WBH)
DIMETHICONOL (2000 CST) (UNII: T74O12AN6Y)
BENZOIC ACID (UNII: 8SKN0B0MIM)
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)
ANHYDROXYLITOL (UNII: 8XWR7NN42F)
PALMITOYL PENTAPEPTIDE-4 (UNII: KK181SM5JG)
POLYACRYLIC ACID (8000 MW) (UNII: 73861X4K5F)
XYLITYLGLUCOSIDE (UNII: O0IEZ166FB)
EDETATE DISODIUM (UNII: 7FLD91C86K)
DIMETHICONE (UNII: 92RU3N3Y1O)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 83447-014-01	50 g in 1 BOTTLE; Type 0: Not a Combination Product	12/08/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	12/08/2025

Labeler - Guangzhou Fantesy Biotechnology Co.,Ltd (619047084)

Establishment
Name	Address	ID/FEI	Business Operations
Guangzhou Fantesy Biotechnology Co.,Ltd		619047084	manufacture(83447-014)